Market research
TFHD.F THC Biomed Intl Ltd
F EUR Healthcare
Latest close
As of 19 Oct 2025
Test a moving-average rule with historical data.
Market facts
- Market cap
- 2M
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- 0.46
Profile
Instrument facts
- Exchange
- F
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- ISIN
- CA87243W1032
- Market cap
- 2M
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- 0.46
About
About THC Biomed Intl Ltd
THC Biomed Intl Ltd. produces and sells medical and recreational cannabis in Canada. It offers cannabis beverage shots, gummies, and biscuits under the THC KISS brand names, as well as pure cannabis sticks. The company was founded in 2012 and is headquartered in Kelowna, Canada.
Research context
THC Biomed Intl Ltd appears in PyInvesting’s Frankfurt Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the TFHD.F discussion.
5 years, 6 months ago
THC Biomed Intl Ltd is currently in a long term downtrend where the price is trading 8.8% below its 200 day moving average.
From a valuation standpoint, the stock is 99.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 6.3.
THC Biomed Intl Ltd's total revenue sank by 50.1% to $622K since the same quarter in the previous year.
Its net income has dropped by 884.9% to $-692K since the same quarter in the previous year.
Finally, its free cash flow fell by 501.8% to $-118K since the same quarter in the previous year.
Based on the above factors, THC Biomed Intl Ltd gets an overall score of 1/5.